[EN] ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS<br/>[FR] DÉRIVÉS D'ISOXAZOLOPYRIDINE DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT D'ÉTATS À MÉDIATION PAR HIF
申请人:FIBROGEN INC
公开号:WO2009073669A1
公开(公告)日:2009-06-11
The present invention relates to novel compounds of formula (I) capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.
本发明涉及一类新的公式(I)化合物,能够通过抑制至少一种HIF羟基化酶的活性来调节低氧诱导因子(HIF)的稳定性和/或活性。